Clinical Trial Update: Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions [Phase 2]

View source ↗

Summary

Phase 2 study evaluating once-daily oral RGT001-075 versus placebo in adults with obesity or overweight and weight-related health conditions. The trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• RGT001-075

Snippet

Sponsor: Regor Pharmaceuticals Inc. | Conditions: Obesity or Overweight | Phase 2 | Status: ACTIVE_NOT_RECRUITING